Epoch Investment Partners Inc. lifted its position in Chemed Co. (NYSE:CHE - Free Report) by 5.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 252,237 shares of the company's stock after buying an additional 12,167 shares during the quarter. Epoch Investment Partners Inc. owned about 1.68% of Chemed worth $133,635,000 as of its most recent filing with the SEC.
A number of other hedge funds have also recently added to or reduced their stakes in CHE. MML Investors Services LLC grew its holdings in Chemed by 3.9% during the third quarter. MML Investors Services LLC now owns 1,457 shares of the company's stock valued at $876,000 after purchasing an additional 55 shares during the last quarter. Franklin Resources Inc. raised its stake in shares of Chemed by 21.3% in the 3rd quarter. Franklin Resources Inc. now owns 8,800 shares of the company's stock valued at $5,282,000 after buying an additional 1,544 shares in the last quarter. Central Pacific Bank Trust Division lifted its holdings in shares of Chemed by 11.4% during the 4th quarter. Central Pacific Bank Trust Division now owns 880 shares of the company's stock worth $466,000 after acquiring an additional 90 shares during the period. Nordea Investment Management AB increased its stake in Chemed by 4.9% in the fourth quarter. Nordea Investment Management AB now owns 13,639 shares of the company's stock valued at $7,242,000 after acquiring an additional 635 shares during the period. Finally, Harbor Capital Advisors Inc. lifted its stake in Chemed by 18.4% during the fourth quarter. Harbor Capital Advisors Inc. now owns 3,188 shares of the company's stock worth $1,689,000 after purchasing an additional 496 shares during the period. Institutional investors and hedge funds own 95.85% of the company's stock.
Insiders Place Their Bets
In related news, CEO Kevin J. Mcnamara sold 1,000 shares of the company's stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $615.33, for a total transaction of $615,330.00. Following the transaction, the chief executive officer now owns 101,679 shares in the company, valued at $62,566,139.07. This represents a 0.97 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 3.32% of the company's stock.
Wall Street Analyst Weigh In
CHE has been the subject of a number of recent research reports. Royal Bank of Canada increased their target price on Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a report on Friday, March 14th. StockNews.com raised Chemed from a "hold" rating to a "buy" rating in a report on Friday, March 7th.
Read Our Latest Stock Analysis on CHE
Chemed Stock Performance
Shares of NYSE CHE traded down $26.59 during mid-day trading on Thursday, hitting $558.88. 132,373 shares of the stock were exchanged, compared to its average volume of 113,715. Chemed Co. has a twelve month low of $512.12 and a twelve month high of $623.60. The stock's fifty day simple moving average is $587.66 and its two-hundred day simple moving average is $567.54. The company has a market cap of $8.17 billion, a P/E ratio of 28.16, a PEG ratio of 2.15 and a beta of 0.49.
Chemed Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were given a $0.50 dividend. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 annualized dividend and a yield of 0.36%. Chemed's payout ratio is 10.05%.
Chemed Company Profile
(
Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Read More

Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.